These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30911636)

  • 1. Normothermic intraperitoneal chemotherapy long term (NIPEC-LT) in the management of peritoneal surface malignancy, an overview.
    Sugarbaker PH
    Pleura Peritoneum; 2017 Jun; 2(2):85-93. PubMed ID: 30911636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the management of malignant peritoneal mesothelioma.
    Sugarbaker PH
    Transl Lung Cancer Res; 2018 Oct; 7(5):599-608. PubMed ID: 30450299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
    Sugarbaker PH; Chang D
    Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them.
    Sugarbaker PH
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1393-1401. PubMed ID: 31725340
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies to improve local control of resected pancreas adenocarcinoma.
    Sugarbaker PH
    Surg Oncol; 2017 Mar; 26(1):63-70. PubMed ID: 28317586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of peritoneal metastases - Basic concepts.
    Sugarbaker PH
    J BUON; 2015 May; 20 Suppl 1():S2-11. PubMed ID: 26051329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects.
    Sugarbaker PH
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S231-S239. PubMed ID: 33968440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year survival of pancreas cancer with liver metastases treated by intraoperative and long-term intraperitoneal gemcitabine. A case report.
    Sugarbaker PH; Steves MA
    Int J Surg Case Rep; 2023 Jun; 107():108313. PubMed ID: 37209455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to Nivolumab followed by complete cytoreductive surgery with HIPEC resulted in long-term survival in a patient with sarcomatoid-predominant biphasic peritoneal mesothelioma. A case report.
    Sugarbaker PH
    Int J Surg Case Rep; 2023 Jun; 107():108359. PubMed ID: 37267791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions.
    Sugarbaker PH; Stuart OA
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S99-S109. PubMed ID: 33968430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens.
    Brandl A; Prabhu A
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S32-S44. PubMed ID: 33968424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis.
    Sugarbaker PH; Chang D
    Ann Surg Oncol; 2021 Nov; 28(12):7109-7117. PubMed ID: 33942167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases.
    Sun BJ; Lee B
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series.
    Sugarbaker PH; Stuart OA
    Surg Oncol; 2020 Jun; 33():96-99. PubMed ID: 32561104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis.
    Frassini S; Calabretto F; Granieri S; Fugazzola P; Viganò J; Fazzini N; Ansaloni L; Cobianchi L
    Eur J Surg Oncol; 2022 Sep; 48(9):1911-1921. PubMed ID: 35688711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 17. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
    Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
    Eur J Cancer; 2020 Mar; 127():76-95. PubMed ID: 31986452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.
    Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
    Curr Oncol; 2020 Jun; 27(3):146-154. PubMed ID: 32669924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing regional chemotherapy for epithelial ovarian cancer.
    Sugarbaker PH
    J Obstet Gynaecol Res; 2022 Jun; 48(6):1306-1317. PubMed ID: 35343033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies.
    Morris MC; Cloyd JM; Hays J; Patel SH
    J Gastrointest Surg; 2021 Jan; 25(1):303-318. PubMed ID: 32808135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.